PE2399A1 - Vacunas de micosis - Google Patents
Vacunas de micosisInfo
- Publication number
- PE2399A1 PE2399A1 PE1997000879A PE00087997A PE2399A1 PE 2399 A1 PE2399 A1 PE 2399A1 PE 1997000879 A PE1997000879 A PE 1997000879A PE 00087997 A PE00087997 A PE 00087997A PE 2399 A1 PE2399 A1 PE 2399A1
- Authority
- PE
- Peru
- Prior art keywords
- dsm
- yeast
- liquid medium
- treatment
- vaccines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/165—Yeast isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/72—Candida
- C12R2001/725—Candida albicans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
CARACTERIZADA PORQUE COMPRENDE MICROCONIDIOS DE DERMATOFITOS Y BLASTOESPORAS DE LEVADURAS O EL MATERIAL ANTIGENICO DE DICHAS ESPORAS, LOS CUALES SE ENCUENTRAN INACTIVADOS Y/O HOMOGENIZADOS Y AL MENOS UN 50% SE ENCUENTRA HINCHADO Y/O TIENEN TUBOS GERMINALES, EN DONDE: DICHAS BLASTOESPORAS PERTENECEN A LAS CEPAS DSM 9456 Y/O 9457 Y/O 9458 Y/O 9459 DE CANDIDA ALBICANS, Y, DICHOS MICROCONIDIOS PERTENECEN A LAS CEPAS DSM 9469 Y/O 9470 Y/O 9471 Y/O 9472 DE TRICHOPHYTON RUBRUM Y/O LA CEPA DSM 7279 DE TRICHOPHYTON MENTAGROPHYTES Y/O LA CEPA DSM 7281 DE MICROSPORUM CANIS; ESTAS ESPORAS FUNGICAS HAN SIDO INACTIVADAS CON TIOMERSAL, FORMALDEHIDO o 2-PROPIOLACTONA Y LUEGO MODIFICADOS POR TRATAMIENTO CON H2O2 O SALES DE MnO4. TAMBIEN SE REFIERE A SU PROCEDIMIENTO DE PREPARACION, QUE COMPRENDE: (A) HACER CRECER UN DERMATOFITO EN UN MEDIO SOLIDO (EXTRACTO DE MALTA O AGAR DE SABOURAUD), COSECHAR Y HOMOGENIZARLO EN UN MEDIO LIQUIDO; (B) HACER CRECER UNA LEVADURA EN UN MEDIO SOLIDO, COSECHAR, HOMOGENIZAR EN UN MEDIO LIQUIDO DE pH: 6,8-7, E INCUBAR EN UNA ATMOSFERA CON 5% A 6% DE CO2 POR 2-4 h; (C) COMBINAR E INACTIVAR LOS MATERIALES HOMOGENIZADOS DE (A) Y (B). ESTAS VACUNAS DE PREFERENCIA EN UNA CONCENTRACION DE 60 MILLONES DE ESPORAS POR ml, SON UTILES EN EL TRATAMIENTO DE MICOSIS CUTANEAS COMO DERMATOMICOSIS Y/O CANDIDIASIS Y/U ONICOMICOSIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96115954A EP0834322A3 (en) | 1996-10-04 | 1996-10-04 | Mycosis vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
PE2399A1 true PE2399A1 (es) | 1999-02-10 |
Family
ID=8223269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1997000879A PE2399A1 (es) | 1996-10-04 | 1997-10-02 | Vacunas de micosis |
Country Status (17)
Country | Link |
---|---|
US (1) | US6290950B1 (es) |
EP (2) | EP0834322A3 (es) |
JP (1) | JP4698771B2 (es) |
AR (1) | AR008491A1 (es) |
AT (1) | ATE347372T1 (es) |
AU (1) | AU740389B2 (es) |
CA (1) | CA2268138C (es) |
CO (1) | CO4650185A1 (es) |
DE (1) | DE69737067T2 (es) |
DK (1) | DK0956042T3 (es) |
ES (1) | ES2279546T3 (es) |
HR (1) | HRP970528A2 (es) |
PE (1) | PE2399A1 (es) |
PT (1) | PT956042E (es) |
RU (1) | RU2219945C2 (es) |
WO (1) | WO1998015284A2 (es) |
ZA (1) | ZA978799B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2020959C1 (ru) * | 1991-10-21 | 1994-10-15 | Игорь Дмитриевич Поляков | Вакцина поливак-тм для профилактики и лечения дерматофитозов животных |
US6720576B1 (en) * | 1992-09-11 | 2004-04-13 | Semiconductor Energy Laboratory Co., Ltd. | Plasma processing method and photoelectric conversion device |
GB2304347A (en) | 1995-08-11 | 1997-03-19 | Boeringer Ingelheim Vetmedica | Antigenic preparations |
WO2001015725A1 (en) * | 1998-09-24 | 2001-03-08 | Alpharma As | Vaccine for the protection of a vertebrate animal against fungal skin infection |
CA2411912C (en) * | 2000-06-19 | 2014-06-17 | Candivax Pty Ltd. | Compositions and methods for treatment of candidiasis |
US20040043003A1 (en) * | 2002-01-31 | 2004-03-04 | Wei Chen | Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
US20040009937A1 (en) * | 2002-01-31 | 2004-01-15 | Wei Chen | Methods and composition for delivering nucleic acids and/or proteins to the respiratory system |
US20050075298A1 (en) * | 2002-01-31 | 2005-04-07 | Wei Chen | Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa |
RU2281110C1 (ru) * | 2005-02-10 | 2006-08-10 | Владислав Николаевич Ласкавый | Лекарственное средство против кандидоза человека для инъекций |
EP2063905B1 (en) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
US20080220023A1 (en) * | 2007-03-08 | 2008-09-11 | Stevens David A | Antifungal vaccines with saccharomyces cerevisiae |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
US11173193B2 (en) | 2016-03-15 | 2021-11-16 | Igor Polyakov | Immunobiological products |
EP3429616B1 (en) * | 2016-03-15 | 2021-08-04 | Igor Polyakov | Compositions for the treatment and prevention of hoof and claw diseases |
WO2021001540A1 (en) | 2019-07-04 | 2021-01-07 | Proxi Biotech Aps | Detoxification of proteins |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU547928B2 (en) * | 1981-11-03 | 1985-11-14 | Sutka, K. | Antigenic preparation from candida guilliermondii |
US4762710A (en) * | 1986-06-16 | 1988-08-09 | The United States Of America As Represented By The Department Of Health And Human Services | Novel method of preparing toxoid by oxidation and metal ions |
CA2011896C (en) * | 1989-04-21 | 2001-05-08 | Mark Werner | Ringworm vaccine |
DE4007927A1 (de) * | 1990-03-13 | 1991-09-19 | Bayer Ag | Pathogenese-faktoren von dermatophyten |
US5277904A (en) * | 1990-10-26 | 1994-01-11 | Pier Allan C | Broad spectrum dermatophyte vaccine |
RU2020959C1 (ru) * | 1991-10-21 | 1994-10-15 | Игорь Дмитриевич Поляков | Вакцина поливак-тм для профилактики и лечения дерматофитозов животных |
GB9417880D0 (en) * | 1994-09-06 | 1994-10-26 | Auspharm Int Ltd | Vaccine |
GB2304347A (en) * | 1995-08-11 | 1997-03-19 | Boeringer Ingelheim Vetmedica | Antigenic preparations |
CA2264496C (en) * | 1996-09-04 | 2008-10-07 | Takara Shuzo Co., Ltd. | Fungal antigens and process for producing the same |
-
1996
- 1996-10-04 EP EP96115954A patent/EP0834322A3/en not_active Withdrawn
-
1997
- 1997-09-22 AT AT97942957T patent/ATE347372T1/de active
- 1997-09-22 DK DK97942957T patent/DK0956042T3/da active
- 1997-09-22 CA CA002268138A patent/CA2268138C/en not_active Expired - Fee Related
- 1997-09-22 JP JP51711998A patent/JP4698771B2/ja not_active Expired - Fee Related
- 1997-09-22 ES ES97942957T patent/ES2279546T3/es not_active Expired - Lifetime
- 1997-09-22 EP EP97942957A patent/EP0956042B1/en not_active Expired - Lifetime
- 1997-09-22 DE DE69737067T patent/DE69737067T2/de not_active Expired - Lifetime
- 1997-09-22 WO PCT/EP1997/005181 patent/WO1998015284A2/en active IP Right Grant
- 1997-09-22 PT PT97942957T patent/PT956042E/pt unknown
- 1997-09-22 RU RU99108989/15A patent/RU2219945C2/ru active
- 1997-09-22 US US09/269,342 patent/US6290950B1/en not_active Expired - Lifetime
- 1997-09-22 AU AU44604/97A patent/AU740389B2/en not_active Ceased
- 1997-10-01 ZA ZA9708799A patent/ZA978799B/xx unknown
- 1997-10-02 CO CO97057661A patent/CO4650185A1/es unknown
- 1997-10-02 PE PE1997000879A patent/PE2399A1/es not_active Application Discontinuation
- 1997-10-02 HR HR96115954.8A patent/HRP970528A2/hr not_active Application Discontinuation
- 1997-10-03 AR ARP970104552A patent/AR008491A1/es not_active Suspension/Interruption
Also Published As
Publication number | Publication date |
---|---|
EP0956042A2 (en) | 1999-11-17 |
DE69737067T2 (de) | 2007-07-05 |
EP0834322A3 (en) | 1998-04-22 |
EP0834322A2 (en) | 1998-04-08 |
ZA978799B (en) | 1998-04-06 |
CO4650185A1 (es) | 1998-09-03 |
PT956042E (pt) | 2007-04-30 |
AR008491A1 (es) | 2000-01-19 |
DK0956042T3 (da) | 2007-04-10 |
EP0956042B1 (en) | 2006-12-06 |
JP4698771B2 (ja) | 2011-06-08 |
WO1998015284A3 (en) | 1999-09-23 |
AU4460497A (en) | 1998-05-05 |
CA2268138A1 (en) | 1998-04-16 |
US6290950B1 (en) | 2001-09-18 |
ES2279546T3 (es) | 2007-08-16 |
RU2219945C2 (ru) | 2003-12-27 |
HRP970528A2 (en) | 1998-08-31 |
CA2268138C (en) | 2009-01-06 |
DE69737067D1 (de) | 2007-01-18 |
ATE347372T1 (de) | 2006-12-15 |
AU740389B2 (en) | 2001-11-01 |
JP2001503975A (ja) | 2001-03-27 |
WO1998015284A2 (en) | 1998-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE2399A1 (es) | Vacunas de micosis | |
Pitt et al. | Pathogenicity and epidemiology of Botryosphaeriaceae species isolated from grapevines in Australia | |
Billones-Baaijens et al. | A review of Botryosphaeriaceae species associated with grapevine trunk diseases in Australia and New Zealand | |
Veloukas et al. | Fitness and competitive ability of Botrytis cinerea field isolates with dual resistance to SDHI and QoI fungicides, associated with several sdh B and the cyt b G143A mutations | |
Yao et al. | Effects of a biocontrol agent and methyl jasmonate on postharvest diseases of peach fruit and the possible mechanisms involved | |
Konstantinou et al. | Population structure, fungicide resistance profile, and sdhB mutation frequency of Botrytis cinerea from strawberry and greenhouse-grown tomato in Greece | |
Luque et al. | Pathogenicity of fungi isolated from Quercus suber in Catalonia (NE Spain) | |
Kunova et al. | Metrafenone resistance in a population of Erysiphe necator in northern Italy | |
Cotoras et al. | Farnesol induces apoptosis-like phenotype in the phytopathogenic fungus Botrytis cinerea | |
Acheampong et al. | Temperature tolerance and humidity requirements of select entomopathogenic fungal isolates for future use in citrus IPM programmes | |
Dugan et al. | Incidence, aggressiveness and in planta interactions of Botrytis cinerea and other filamentous fungi quiescent in grape berries and dormant buds in Central Washington State | |
Li et al. | Alternaria tenuissima causing leaf spot and fruit rot on pepper (Capsicum annuum): first report in China | |
Sosnowski et al. | The influence of water deficit stress on the grapevine trunk disease pathogens Eutypa lata and Diplodia seriata | |
Nusaibah et al. | Antagonistic efficacy of Trichoderma harzianum and Bacillus cereus against Ganoderma disease of oil palm via dip, place and drench (DPD) artificial inoculation technique | |
Schmitz et al. | First report of Neonectria neomacrospora on Abies grandis in Belgium | |
Yin et al. | The natural fenhexamid‐resistant grey mould populations from strawberry in Zhejiang Province are dominated by Botrytis cinerea group S | |
Fischer et al. | Impact of Quillaja saponaria saponins on grapevine ecosystem organisms | |
Rueda‐Hernández et al. | Differential organ distribution, pathogenicity and benomyl sensitivity of Colletotrichum spp. from blackberry plants in Northern Colombia | |
Karkee et al. | Efficacy of fungicides against Rhizoctonia solani inciting rhizome rot diseases on large cardamom (Amomum subulatum Roxb.) | |
Pathan et al. | The puzzle of highly virulent Metarhizium anisopliae strains from Annona squamosa fields against Helicoverpa armigera | |
Travadon et al. | Field evaluation of biological wound treatments for the management of almond, cherry, and grapevine fungal canker diseases | |
Tongon et al. | Fungal metabolites from Chaetomium brasiliense to inhibit Fusarium solani | |
Banerjee et al. | First report of leaf blight and twig dieback caused by Mycoleptodiscus indicus on Ixora coccinea | |
Golmohammadi et al. | Neofusicoccum parvum associated with pomegranate branch canker in Iran | |
Martinez et al. | Ultrastructure of the infection process of potato tuber by Helminthosporium solani, causal agent of potato silver scurf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |